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434a Tuesday, February 28, 2012Negatively-charged lipid membranes have been suggested to trigger ‘‘amyloid-
like’’ fibril formation by several non-amyloidogenic proteins, e.g. lysozyme
[1]. We aimed to elucidate the factors that govern the formation of these ‘‘am-
yloid-like’’ fibrils and to characterize their structural and dynamical properties.
Lysozyme was labeled with Alexa 488 (A488-Lz) and its interaction with
POPC LUVs containing 20 and 30 mol% of POPS was studied using both
steady-state and time-resolved fluorescence techniques. The variation of the
mean fluorescence lifetime of A488-Lz as a function of the surface coverage
of the liposomes was quantitatively described by a three-state model that as-
sumes that monomeric lysozyme molecules partition into the bilayer surface
and reversibly assemble into oligomers with N subunits (NR 6) (cooperative
partition model). The global fit was done using the partition coefficients previ-
ously determined for A488-Lz by fluorescence correlation spectroscopy (FCS)
[2] and by taking into account electrostatic effects by means of the Gouy-
Chapman theory. To better evaluate the oligomerization state of membrane-
bound lysozyme, the steady-state fluorescence anisotropy of A488-Lz was
also measured for two different fluorophore labeling. The extent of energy mi-
gration between A488-Lz (decrease in fluorescence anisotropy) was adequately
described only for N= 65 1 when the binomial distribution of fluorescently-
labeled monomers among the oligomers was considered. Finally, the lipid-
protein supramolecular complexes formed at a low lipid/protein molar ratio
[1] were characterized by fluorescence lifetime imaging microscopy (FLIM).
The average fluorescence lifetime of A488-Lz had a uniform spatial distribu-
tion on these structures, being much shorter than the values measured for
free and membrane-bound monomeric A488-Lz, reporting the aggregated state
of lysozyme.
[1] Zhao et al. 2004 Biochemistry 43: 10302
[2] Melo et al. 2011 Biochim. Biophys. Acta 1808: 2559
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Pmel17 is a structural protein involved in melanin synthesis and deposition that
forms fibrous striations in melanosomes, acidic organelles where pigmentation
occurs. It was recently shown that a fragment of Pmel17 named the repeat do-
main (RPT, residues 315-444) is responsible for fibril formation in vitro under
mildly acidic conditions. (McGlinchey RP. et al., PNAS, 2009; Pfefferkorn
CM. et al., PNAS, 2010; McGlinchey RP. et al., JBC, 2010) Moreover, at neu-
tral pH these fibrils disassemble, supporting a highly reversible aggregation/
disaggregation process that could be a way for melanosomes to recycle amyloid
fibrils. Here, we investigate the conformation and aggregation state of the RPT
domain in the presence of membrane mimics, since it is localized in a membra-
nous organelle. Specifically, micelles formed from detergents like sodium do-
decyl sulfate or from lipids such as lysolipid as well as phospholipid vesicles
were examined. Along with circular dichroism spectroscopy, which reports
on the formation of secondary structure, we exploited the sole intrinsic Trp flu-
orophore (W423) located at the C-terminal region as a site-specific probe of in-
teraction. To determine the specificity of this interaction, we also produced and
examined single Trp mutants at the N-terminal region. Because the melano-
some is an acidic organelle, we also explored the pH dependence of interaction
in detail. Finally, we carried out aggregation experiments in the presence of
lipid monomers and micelles in determining their effects on fibril formation.
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Cell membranes, including their individual components like membrane-bound
proteins and particular lipids, attract a growing attention as very perspective
pharmacological targets. Rational design of new efficient and selective com-
pounds modulating activity of biomembranes, requires atomic-scale informa-
tion on their spatial structure and dynamics under different conditions.
Because such details resist easy experimental characterization, important in-
sight can be gained via computer simulations.
We present the results of structural/dynamic computational studies of mem-
brane proteins and peptides with diverse fold, mode of membrane binding,
and biological activities: antimicrobial and cell-penetrating peptides, cardio-toxins from snake venom, transmembrane domains of receptor tyrosine ki-
nases. The computational approach combines Monte Carlo simulations in
implicit membranes, molecular dynamics in full-atom lipid bilayers, and mo-
lecular hydrophobicity potential analysis. The predictive power of the method
was proven via testing against high-resolution experimental data.
Despite different structure and mechanism of membrane permeation, in all
cases the polypeptide-membrane recognition reveals a prominent ‘‘self-adapt-
ing’’ character. Namely, the membrane active agents employ a wide arsenal of
structural/dynamic tools in order to insert into lipid bilayer and to accomplish
their function. Importantly, lipid bilayer of biological membranes plays essen-
tial role in the recognition/binding events. In particular, the membrane surface
reveals highly dynamic lateral heterogeneities (clusters), which differ in their
packing and hydrophobic properties from the bulk lipids. Such a mosaic nature
of membranes is tuned in a wide range by the chemical nature and relative con-
tent of lipids, presence of ions, etc. This makes possible mutual adaptation of
the two amphiphatic systems (peptide and membrane). Such a diversity of
the factors important for polepeptide-bilayer interactions assures their efficient
and robust binding to cell membranes. Understanding of such effects creates
a basis for rational design of new physiologically active molecules and/or arti-
ficial membranes with predefined properties.
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Mitochondria are the power plants of the cell. Most of the ATP used by a cell is
produced by the respiratory chain located in the inner membrane of
mitochondria.
It is now well accepted that the protein complexes forming the respiratory chain
assemble into larger structures, the so-called supercomplexes[1]. The lack of
cardiolipin (CL), a double charged phosphoslipid composing more than 10%
of the mitochondrial membrane, impairs the formation of these supercom-
plexes[2,3] and affects their functionality in the respiratory chain[4].
To investigate the mechanism by which CLs favor the formation of supercom-
plexes we have simulated complexes III and IV embedded in POPC bilayers
containing CLs. The use of the MARTINI coarse grained force field[5] was
necessary to reach the system size and time scale necessary to this study.
Most notably we found that CLs present preferential interfaces on both com-
plexes III and IV. This led us to the hypothesis that these interfaces might
play a role in the relative orientation of the complexes in the supercomplexes.
This was clearly shown by the comparison of the supercomplexes formed dur-
ing self-assembly simulations of a mixture of the two complexes in a lipid bi-
layer with and without CLs present.
[1] Lenaz G. et al in International Journal of Biochemistry and Cell Biology 41
(2009).
[2] Zhang M. et al in Journal of Biological Chemistry 277 (2002).
[3] Pfeiffer K. et al in Journal of Biological Chemistry 278 (2003).
[4] Claypool S.M. in Biochimica et Biophysica Acta - Biomembranes 1788
(2009).
[5] Monticelli L. et al in Journal of Chemical Theory and Computation 4 (2008).
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Cholesterol is one of the most efficient modulators of G Protein-Coupled Re-
ceptor (GPCR) function. We monitored the effect of cholesterol on rhodopsin
function for a set of bilayers with different hydrophobic thickness. Surprisingly,
cholesterol shifts the Metarhodopsin-I (MI)/Metarhodopsin-II (MII) equilib-
rium toward MII for bilayers thinner than the average length of hydrophobic
transmembrane helices (2.7 nm), and to MI for thicker bilayers. In previous
work conducted on rod outer segment disks and model membranes, increasing
cholesterol concentration always shifted the equilibrium towards MI. It was
proposed that the cholesterol effect is primarily related to a tighter packing
of lipid hydrocarbon chains which generates a less permissive environment
for the formation of MII. To gain deeper insights into mechanisms, we followed
changes in lipid-rhodopsin interaction by 2H NMR using deuterated lipids. It
was reported by us and the Brown laboratory that an increase of bilayer hydro-
phobic thickness in the absence of cholesterol favors MII with a turnover to MI
for bilayers that are very thick. Indeed, the cholesterol-induced shifts towards
MII for thinner membranes correlated nicely with the cholesterol-induced in-
crease of bilayer hydrophobic thickness measured by NMR suggesting that
the increase in bilayer thickness by cholesterol plays a major role in controlling
the energetics of the MI-MII equilibrium. Furthermore, changes in average
Tuesday, February 28, 2012 435alipid order parameters due to the presence of rhodopsin were much larger in
cholesterol-containing membranes than in cholesterol-free membranes suggest-
ing strongly that the perturbation in the lipid matrix from protein insertion rea-
ches much further away from the protein. This is expected for membranes that
are stiffer due to the presence of cholesterol. The consequences of these find-
ings for lipid mediated shifts in rhodopsin function and rhodopsin-rhodopsin in-
teractions will be discussed.Platform: Cardiac Muscle: Myosin Binding
Proteins
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Cardiac myosin binding protein-C (cMyBP-C) is a thick filament protein that
augments filament stiffness and modulates cardiac contractility through its
phosphorylation. We investigated the effect of cMyBP-C on myosin cross-
bridge kinetics in demembranated papillary muscle strips from non-
transgenic (NTG) and transgenic homozygous mice lacking cMyBP-C (t/t).
Both groups expressed ~100% b-myosin heavy chain isoform due to hypothy-
roidism. Sinusoidal length perturbation analysis at maximal Ca2þ-activation
(pCa 4.8 at 17 C, 0 mM Pi) showed that MgATP-dependent myosin detach-
ment rate (g) increased hyperbolically with MgATP (0.025 to 5 mM), with sat-
urating values of 2.550.2 and 3.950.2 s1 (P<0.01) for NTG and t/t,
respectively. Kinetic analysis of g vs. [MgATP] resulted in a lower [MgATP]50
for NTG than t/t (187545 vs. 361558 mM, P<0.05). As myosin attachment
time (ton) is inversely related to g, ton correspondingly decreased as [MgATP]
increased, with saturating values of 71.355.0 and 44.252.3 ms (P<0.01) for
NTG vs. t/t, respectively. At saturating MgATP, ton decreased as [Pi] increased
in both groups (0-12 mM), although ton remained ~25% longer at each [Pi] for
NTG vs. t/t. Protein kinase-A (PKA) incubation reduced ton ~20% at each [Pi]
for NTG, but did not affect ton for t/t. The longer ton for NTG at saturating
MgATP suggests a longer lived MgADP myosin cross-bridge state when
cMyBP-C is present. The lower [MgATP]50 for NTG further suggests that
cMyBP-C elevates the nucleotide binding pocket affinity for MgATP in addi-
tion to MgADP. cMyBP-C phosphorylation by PKA may diminish this affinity
resulting in a shorter ton. These results support a functional role for cMyBP-C
slowing myosin kinetics, possibly through altered strain-dependent myosin
kinetics due to cMyBP-C supporting a stiffness of the thick filament or myofil-
ament lattice that is diminished with PKA phorphorylation of cMyBP-C.
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We have used double mixing stopped-flow fluorescence to study the effect of
the soluble N-terminal C1C2 domain of cMyBP-C on the activation of product
dissociation from myosin-S1-mdADP-Pi by native porcine thin filaments.
Product dissociation from cardiac actomyosin is an ordered process in which
phosphate dissociation is rate limiting (AM-mdADP-Pi / AM-mdADP /
AM) and can therefore be measured by the rate of mdADP dissociation.
Myosin-S1 was mixed with an equal concentration of the fluorescent ATP an-
alogue, mdATP, and held in a delay line 2 seconds for the nucleotide to bind
and be hydrolyzed (M þ mdATP/ M-mdATP4M-mdADP-Pi). The mix-
ture was subsequently mixed with native cardiac thin filaments, 1 mMMgATP,
1 mM EGTA and expressed mouse cMyBP-C domains C1C2. In control exper-
iments cMyBP-C was either replaced with NEM-S1 (a catalytically inactive
form of myosin-S1, modifed with N-ethylmaleimide, which binds to actin in
the presence of ATP), rigor myosin-S1 (in the absence of ATP) or 0.1 mM
CaCl2. Maximal activation of the rate of product dissociation by cMyBP-C
domains C1C2 is the same as observed with saturating rigor-myosin-S1 or
0.1 mM calcium and greater than observed with NEM-S1. These experiments
were done at physiological ionic strength (0.18 M KAc, 10 mM Mops, 2 mM
MgCl2, pH 7) to eliminate non specific ionic interaction that might occur at
lower ionic strength. Cardiac cMyBP-C domains C1C2 not only bind to actin
at a similar position to rigor myosin-S1 but substoichiometric concentrations
(1 cMyBP-C C1C2 per 7 actin subunits) are as effective as rigor myosin-S1
at activating cardiac thin filament in the absence of calcium.2209-Plat
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We have determined the effects of Myosin binding protein-C (MyBP-C) and its
domains on the microsecond time-scale rotational dynamics of actin, using
time-resolved phosphorescence anisotropy (TPA). MyBP-C is a multi-
domain thick filament-associated modulator of striated muscle contraction,
spanning the interfilament spacing to contact both myosin and actin. Cardiac
(c-) and slow skeletal (ss-) MyBP-C are known substrates for Protein kinase-
A (PKA), and phosphorylation of cMyBP-C alters contractile properties and
myofilament structure. To determine the effects of MyBP-C on actin’s micro-
second structural dynamics, we labeled actin at C374 with erythrosine iodoace-
tamide and performed TPA experiments. The interaction of all three MyBP-C
isoforms with actin increased the final anisotropy (rN) of the TPA decay in
a concentration-dependent manner, indicating restriction of the rotational am-
plitude of actin dynamics. While PKA phosphorylation had little effect on fast
skeletal (fs-) MyBP-C, phosphorylation of cMyBP-C and ssMyBP-C nearly
eliminated the effects of these proteins to restrict actin dynamics, despite no
change in binding affinity with phosphorylation. Skeletal MyBP-C (C1-C10)
affected actin anisotropy at lower concentrations than cMyBP-C (C0-C10),
suggesting that skeletal and cardiac N-terminal MyBP-C interactions with actin
have distinct properties. The effects of truncated cMyBP-C on actin anisotropy
determined that C-terminal domains are important for restricting rotational
dynamics, whereas N-terminal domains are important for regulating this effect.
These MyBP-C-induced changes in actin dynamics may play a role in the
known effects of MyBP-C on the functional actin-myosin interaction. This
work was funded by grants from NIH (F32 HL107039-01 to BAC and T32
AR007612 to DDT).
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Myosin Binding Protein-C (MyBP-C), a family of accessory proteins of stri-
ated muscles, contributes to the assembly and stabilization of thick filaments,
and regulates the formation of actomyosin cross-bridges. Three distinct
MyBP-C isoforms have been characterized; cardiac, slow skeletal and fast
skeletal. The slow isoform, sMyBP-C, consists of four alternatively spliced
forms, variants 1-4 (v1-4) that share common structures and sequences. Var-
iants 1-4 differ, however, in three regions; v1 and v2 contain a 25-residue long
insertion within the NH2-terminus, v3 carries an 18-amino acid long segment
within immunoglobulin domain C7 and v1 contains a unique COOH-terminus
consisting of 26 amino acids, while v4 does not possess any of these inser-
tions. Variants 1-4 are expressed in variable amounts among skeletal muscles,
exhibiting different topographies and potentially distinct functions. To date,
the regulatory mechanisms that modulate the activities of sMyBP-C are
unknown. Using an array of proteomic approaches, we show that sMyBP-C
comprises a family of phosphoproteins that are substrates for PKA and
PKC. The levels of phosphorylated skeletal MyBP-C proteins (i.e. slow and
fast) are increased in mouse dystrophic muscles, although their overall
amounts are decreased. In vitro binding and motility assays indicate that
sMyBP-C modulates the formation of actomyosin cross-bridges through inter-
actions with both actin and myosin. Importantly, the presence of the novel
insertions differentially affects the ability of sMyBP-C variants 1-4 to modu-
late cross-bridges formation. In summary, our studies are the first to show
that sMyBP-C comprises a subfamily of phosphoproteins that differentially
regulate actomyosin crossbridges.
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During recent years it has become increasingly evident that cardiac myosin
binding protein C (cMyBP-C) exerts an important role in regulation of
